Johnson Matthey Beats Fraud Claim Over £325M Pharma Deal
Johnson Matthey defeated on Friday a claim that it acted fraudulently in the £325 million ($444 million) sale of one of its pharmaceutical businesses, despite a finding by a London court...To view the full article, register now.
Already a subscriber? Click here to view full article